Almirall, S.A. (BME:ALM)

Market Cap	1.95B
Revenue (ttm)	953.49M
Net Income (ttm)	-44.87M
Shares Out	213.47M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	43.49
Dividend	0.18 (2.01%)
Ex-Dividend Date	May 17, 2024

Volume	91,023
Average Volume	117,455
Open	9.06
Previous Close	9.15
Day's Range	9.11 - 9.21
52-Week Range	7.85 - 10.04
Beta	0.41
RSI	54.91
Earnings Date	Feb 24, 2025

About Almirall

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 1,904
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ALM